Breast cancer-related lymphedema: Symptoms, diagnosis, risk reduction, and management.
Identifieur interne : 001641 ( PubMed/Checkpoint ); précédent : 001640; suivant : 001642Breast cancer-related lymphedema: Symptoms, diagnosis, risk reduction, and management.
Auteurs : Mei R. Fu [États-Unis]Source :
- World journal of clinical oncology [ 2218-4333 ] ; 2014.
Abstract
The global burden of breast cancer continues to increase largely because of the aging and growth of the world population. More than 1.38 million women worldwide were estimated to be diagnosed with breast cancer in 2008, accounting for 23% of all diagnosed cancers in women. Given that the 5-year survival rate for breast cancer is now 90%, experiencing breast cancer is ultimately about quality of life. Women treated for breast cancer are facing a life-time risk of developing lymphedema, a chronic condition that occurs in up to 40% of this population and negatively affects breast cancer survivors' quality of life. This review offers an insightful understanding of the condition by providing clinically relevant and evidence based knowledge regarding lymphedema symptoms, diagnosis, risk reduction, and management with the intent to inform health care professionals so that they might be better equipped to care for patients.
DOI: 10.5306/wjco.v5.i3.241
PubMed: 25114841
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:25114841Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Breast cancer-related lymphedema: Symptoms, diagnosis, risk reduction, and management.</title><author><name sortKey="Fu, Mei R" sort="Fu, Mei R" uniqKey="Fu M" first="Mei R" last="Fu">Mei R. Fu</name><affiliation wicri:level="2"><nlm:affiliation>Mei R Fu, College of Nursing, New York University, New York, NY 10003, United States.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Mei R Fu, College of Nursing, New York University, New York, NY 10003</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2014">2014</date><idno type="RBID">pubmed:25114841</idno><idno type="pmid">25114841</idno><idno type="doi">10.5306/wjco.v5.i3.241</idno><idno type="wicri:Area/PubMed/Corpus">001400</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001400</idno><idno type="wicri:Area/PubMed/Curation">001400</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001400</idno><idno type="wicri:Area/PubMed/Checkpoint">001400</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001400</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Breast cancer-related lymphedema: Symptoms, diagnosis, risk reduction, and management.</title><author><name sortKey="Fu, Mei R" sort="Fu, Mei R" uniqKey="Fu M" first="Mei R" last="Fu">Mei R. Fu</name><affiliation wicri:level="2"><nlm:affiliation>Mei R Fu, College of Nursing, New York University, New York, NY 10003, United States.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Mei R Fu, College of Nursing, New York University, New York, NY 10003</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author></analytic><series><title level="j">World journal of clinical oncology</title><idno type="ISSN">2218-4333</idno><imprint><date when="2014" type="published">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The global burden of breast cancer continues to increase largely because of the aging and growth of the world population. More than 1.38 million women worldwide were estimated to be diagnosed with breast cancer in 2008, accounting for 23% of all diagnosed cancers in women. Given that the 5-year survival rate for breast cancer is now 90%, experiencing breast cancer is ultimately about quality of life. Women treated for breast cancer are facing a life-time risk of developing lymphedema, a chronic condition that occurs in up to 40% of this population and negatively affects breast cancer survivors' quality of life. This review offers an insightful understanding of the condition by providing clinically relevant and evidence based knowledge regarding lymphedema symptoms, diagnosis, risk reduction, and management with the intent to inform health care professionals so that they might be better equipped to care for patients.</div></front></TEI><pubmed><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">25114841</PMID><DateCreated><Year>2014</Year><Month>08</Month><Day>12</Day></DateCreated><DateCompleted><Year>2014</Year><Month>08</Month><Day>12</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">2218-4333</ISSN><JournalIssue CitedMedium="Print"><Volume>5</Volume><Issue>3</Issue><PubDate><Year>2014</Year><Month>Aug</Month><Day>10</Day></PubDate></JournalIssue><Title>World journal of clinical oncology</Title><ISOAbbreviation>World J Clin Oncol</ISOAbbreviation></Journal><ArticleTitle>Breast cancer-related lymphedema: Symptoms, diagnosis, risk reduction, and management.</ArticleTitle><Pagination><MedlinePgn>241-7</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.5306/wjco.v5.i3.241</ELocationID><Abstract><AbstractText>The global burden of breast cancer continues to increase largely because of the aging and growth of the world population. More than 1.38 million women worldwide were estimated to be diagnosed with breast cancer in 2008, accounting for 23% of all diagnosed cancers in women. Given that the 5-year survival rate for breast cancer is now 90%, experiencing breast cancer is ultimately about quality of life. Women treated for breast cancer are facing a life-time risk of developing lymphedema, a chronic condition that occurs in up to 40% of this population and negatively affects breast cancer survivors' quality of life. This review offers an insightful understanding of the condition by providing clinically relevant and evidence based knowledge regarding lymphedema symptoms, diagnosis, risk reduction, and management with the intent to inform health care professionals so that they might be better equipped to care for patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fu</LastName><ForeName>Mei R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Mei R Fu, College of Nursing, New York University, New York, NY 10003, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>World J Clin Oncol</MedlineTA><NlmUniqueID>101549149</NlmUniqueID><ISSNLinking>2218-4333</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Lymphology. 2009 Dec;42(4):161-75</RefSource><PMID Version="1">20218084</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Surg Oncol. 2010 Jul;17(7):1847-53</RefSource><PMID Version="1">20140528</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Surg Oncol. 2012 Feb;19(2):642-51</RefSource><PMID Version="1">21863361</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lymphology. 2012 Sep;45(3):113-23</RefSource><PMID Version="1">23342931</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Semin Oncol Nurs. 2013 Feb;29(1):50-60</RefSource><PMID Version="1">23375066</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lymphat Res Biol. 2005;3(4):208-17</RefSource><PMID Version="1">16379589</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Am Coll Surg. 2011 Oct;213(4):543-51</RefSource><PMID Version="1">21802319</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Scand J Plast Reconstr Surg Hand Surg. 1997 Jun;31(2):137-43</RefSource><PMID Version="1">9232698</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Surg. 2010 Nov;145(11):1055-63</RefSource><PMID Version="1">21079093</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Scand J Surg. 2003;92(4):287-95</RefSource><PMID Version="1">14758919</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nurs Res. 2003 Nov-Dec;52(6):370-9</RefSource><PMID Version="1">14639083</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>CA Cancer J Clin. 2009 Jan-Feb;59(1):8-24</RefSource><PMID Version="1">19147865</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Am Acad Dermatol. 2002 Jul;47(1):124-7</RefSource><PMID Version="1">12077591</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PM R. 2012 Aug;4(8):580-601</RefSource><PMID Version="1">22920313</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Vasc Endovasc Surg. 1996 Nov;12(4):412-7</RefSource><PMID Version="1">8980428</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nurs Res. 2008 Nov-Dec;57(6):416-25</RefSource><PMID Version="1">19018216</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lymphology. 2003 Jun;36(2):84-91</RefSource><PMID Version="1">12926833</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lymphology. 2013 Jun;46(2):85-96</RefSource><PMID Version="1">24354107</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lymphology. 2001 Mar;34(1):2-11</RefSource><PMID Version="1">11307661</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Pain Symptom Manage. 2009 Dec;38(6):849-59</RefSource><PMID Version="1">19819668</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Filaria J. 2003 Mar 12;2(1):4</RefSource><PMID Version="1">12685942</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lymphology. 2006 Mar;39(1):8-25</RefSource><PMID Version="1">16724506</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2007 Apr;16(4):775-82</RefSource><PMID Version="1">17416770</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Lymphoedema. 2010;5(2):39-48</RefSource><PMID Version="1">25505492</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2011 Dec;130(3):981-91</RefSource><PMID Version="1">21761159</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2009 Sep;117(1):177-82</RefSource><PMID Version="1">18563555</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Psychooncology. 2013 Jul;22(7):1466-84</RefSource><PMID Version="1">23044512</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lymphology. 2012 Mar;45(1):13-25</RefSource><PMID Version="1">22768469</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Invest. 2010 Jan;28(1):54-62</RefSource><PMID Version="1">19916749</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Psychooncology. 2010 Mar;19(3):299-305</RefSource><PMID Version="1">19399782</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Nurs Scholarsh. 2008;40(4):341-8</RefSource><PMID Version="1">19094149</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 2001 Sep 15;92(6):1368-77</RefSource><PMID Version="1">11745212</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Lymphoedema. 2008;3(1):20-25</RefSource><PMID Version="1">25506390</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2009 Apr 20;27(12):2007-14</RefSource><PMID Version="1">19289624</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Am Coll Surg. 2013 Mar;216(3):380-9; quiz 511-3</RefSource><PMID Version="1">23266421</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cochrane Database Syst Rev. 2004;(2):CD003140</RefSource><PMID Version="1">15106192</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cancer Surviv. 2011 Dec;5(4):320-36</RefSource><PMID Version="1">22002586</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nurs Res. 2012 Jul-Aug;61(4):291-9</RefSource><PMID Version="1">22565103</PMID></CommentsCorrections></CommentsCorrectionsList><OtherID Source="NLM">PMC4127597</OtherID><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Breast cancer</Keyword><Keyword MajorTopicYN="N">Diagnosis</Keyword><Keyword MajorTopicYN="N">Lymphedema</Keyword><Keyword MajorTopicYN="N">Management</Keyword><Keyword MajorTopicYN="N">Risk reduction</Keyword><Keyword MajorTopicYN="N">Symptoms</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>12</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>04</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>05</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>8</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>8</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>8</Month><Day>13</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25114841</ArticleId><ArticleId IdType="doi">10.5306/wjco.v5.i3.241</ArticleId><ArticleId IdType="pmc">PMC4127597</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>États-Unis</li></country><region><li>État de New York</li></region></list><tree><country name="États-Unis"><region name="État de New York"><name sortKey="Fu, Mei R" sort="Fu, Mei R" uniqKey="Fu M" first="Mei R" last="Fu">Mei R. Fu</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001641 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 001641 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:25114841
|texte= Breast cancer-related lymphedema: Symptoms, diagnosis, risk reduction, and management.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:25114841" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |